18.07.2012
- Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost...
18.07.2012
- Lower prices, higher taxes and fewer drugs paid for by the state could be the new regime for France's pharmaceutical industry when the government details plans in September for €2...
18.07.2012
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced that it has signed a biologics contract manufacturing agreement with its first...
16.07.2012
- GlaxoSmithKline is expected to announce an agreement to acquire Human Genome Sciences for about $2.8 billion as soon as Monday, ending three months of its hostile pursuit of the U...
12.07.2012
- AstraZeneca has clinched two new deals in neuroscience, underlining the drugmaker's increasing reliance on external projects to refill a sparse pipeline as it tests a new low-cost...
04.07.2012
- This second edition of a very successful book is thoroughly updated with existing chapters completely rewritten while the content has more than doubled from 16 to 36 chapters. As...
03.07.2012
- When Roche paid $46.8 billion in 2009 to gain full ownership of Genentech, fears were rife that the arrival of the Swiss men in suits would stifle the free-wheeling innovative...
29.06.2012
- GlaxoSmithKline has once again extended its $2.6 billion offer to buy long-time partner Human Genome Sciences until July 20 as a hostile stand-off with the U.S. biotech company...
25.06.2012
- FivePrime Therapeutics has entered into research and commercial agreements with Biowa and Lonza to use their Potelligent CHOK1SV Cell Line for the research, development and...
20.06.2012
- Sartorius Stedim Biotech (SSB), an international pharma and biotech supplier, and Bosch Packaging Technology (Bosch), a provider of process technology and packaging solutions for...
